23 May 2013
Keywords: bentley, initiates, ph, ii, trial, insulin, nose
Article | 13 November 2006
The USA's Bentley Pharmaceuticals has initiated a Phase II trial of its human recombinant intranasal insulin spray for the treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 November 2006
© 2013 thepharmaletter.com